FDA places Regulus' Hep C drug on clinical hold; shares dive

June 27 (Reuters) - Regulus Therapeutics Inc said
the U.S. Food and Drug Administration placed on clinical hold
the company's drug to treat chronic hepatitis C virus infection,
sending its shares...